About PhaseV
PhaseV is a clinical trial optimization platform that leverages artificial intelligence and machine learning to transform how biopharma companies and contract research organizations (CROs) design and execute clinical trials. The company provides a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, from trial design and patient selection to site selection and real-time monitoring. PhaseV's platform includes four core products: Trial Optimizer for running millions of trial simulations to refine adaptive, Bayesian, and fixed designs; Response Optimizer for identifying optimal patient subgroups and biomarkers by detecting heterogeneity in clinical data; Portfolio Optimizer for uncovering biological factors driving disease progression using AI-driven causal graphs; and ClinOps Optimizer for precision-guided site selection and real-time trial performance analytics. The company serves over 40 biopharma companies and CROs globally, delivering proven outcomes including 40% reduced enrollment, 50% lower trial costs, 40% shorter trial duration, and 30%+ higher probability of success. PhaseV's approach combines causal machine learning with patient-level data from over 2 million patients across multiple therapeutic areas, enabling sponsors to make data-driven decisions backed by advanced analytics and predictive models. The platform has demonstrated success across multiple therapeutic areas including oncology, metabolic diseases, immunology, neurology, rheumatology, and infectious diseases, with validated case studies showing significant improvements in trial efficiency and patient outcomes.
Clinical Focus
Medical conditions and clinical areas addressed by PhaseV.
Who It Serves
Milestones & Awards
Recent Milestones
Oramed reinitiating previously failed diabetes clinical trial based on PhaseV analysis identifying responsive patient subset. Multiple Phase 2 and Phase 3 trial optimizations across therapeutic areas. ClinOps Innovation Dinner with Insight Partners scheduled May 19 in Boston.
Key Partnerships
Company Details
- Headquarters
- Cambridge, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.